Table 3. the association of histological grades sub-classification and intrinsic subtypes.
A) TCGA cohort | LGG | HGG | ||
---|---|---|---|---|
Intrinsic Subtypes | HG1 | HG1-like | HG3-like | HG3 |
Normal-like | 0 (0%) | 0 (0%) | 0 (0%) | 5 (2.8%) |
Luminal-A | 27 (87.1%) | 92 (91.1%) | 21 (26.9%) | 33 (18.6%) |
Luminal-B | 4 (12.9%) | 8 (7.9%) | 32 (41%) | 62 (35%) |
Basal-like | 0 (0%) | 0 (0%) | 8 (10.3%) | 42 (23.7%) |
ERBB2+ | 0 (0%) | 1 (1%) | 17 (21.8%) | 35 (19.8%) |
Total | 31 (100%) | 101 (100%) | 78 (100%) | 177 (100%) |
Chi-square test of homogeneity within HG3-like and HG3 tumors p-value = 0.06 | ||||
Chi-square test of independence between LGG and HGG tumors versus Normal-like, Luminal A as one class and Luminal B, Basal-like, HER2-enriched tumors as another class p-value = 4.281E-39 |
B) Uppsala and Stockholm cohorts | LGG | HGG | ||
---|---|---|---|---|
Intrinsic Subtypes | HG1 | HG1-like | HG3-like | HG3 |
Normal-Like | 41 (37.3%) | 43 (33.1%) | 3 (5.6%) | 1 (1%) |
No Subtype | 13 (11.8%) | 23 (17.7%) | 4 (7.4%) | 1 (1%) |
Luminal-A | 43 (39.1%) | 50 (38.5%) | 12 (22.2%) | 10 (9.9%) |
Luminal-B | 4 (3.6%) | 6 (4.6%) | 15 (27.8%) | 27 (26.7%) |
ERBB2+ | 6 (5.5%) | 7 (5.4%) | 9 (16.7%) | 20 (19.8%) |
Basal-like | 3 (2.7%) | 1 (0.8%) | 11 (20.4%) | 42 (41.6%) |
Total | 110 (100%) | 130 (100%) | 54 (100%) | 101 (100%) |
Chi-square test of homogeneity within HG1-like and HG1 tumors p-value = 0.43 | Chi-square test of homogeneity within HG3-like and HG3 tumors p-value = 0.25 | |||
Chi-square test of independence between LGG and HGG tumors versus Normal-like, Luminal-A as one class and Luminal-B, Basal-like, HER2-enriched tumors as another class p-value = 2.8e-45 |
Breast cancer intrinsic subtype stratification according to histological and genetic grade classification of TCGA A. Uppsala, and Stockholm B. Breast cancer cohorts:Low-genetic grade LGG (HG1+HG1-like) and high-genetic grade HGG (HG3-like+HG3) are considered two major genetically distinct classes of BC.